Florida Cancer Specialists Expands Veteran Oncology Access with Telehealth, Clinical Trials
Event summary
- Florida Cancer Specialists (FCS) is expanding veteran oncology access through rapid appointments, telehealth, and personalized treatment.
- FCS offers 180+ clinical trials targeting common veteran cancers (prostate, lung, bladder, colorectal, breast).
- FCS received a $1M grant to boost clinical trial enrollment in rural and underserved communities.
- FCS President Lucio N. Gordan, MD, will present at the ASCO 2026 Annual Meeting on May 26, 2026.
The big picture
Florida Cancer Specialists is addressing the 20–40% higher cancer risk among veterans with a scalable model combining rapid access, telehealth, and clinical research. This aligns with broader trends in community oncology, where personalized medicine and decentralized trials are reshaping care delivery. With over 180 active trials, FCS is positioning itself as a leader in veteran-focused oncology, potentially influencing national VA partnerships.
What we're watching
- Telehealth Scaling
- How FCS's telehealth expansion will affect rural veteran access and operational efficiency.
- Clinical Trial Growth
- Whether FCS can sustain high enrollment rates in underserved communities post-grant funding.
- Regulatory Alignment
- The pace at which FCS integrates VA protocols to streamline veteran care coordination.
Related topics